LOCOREGIONAL RECURRENCE
Clinical trials for LOCOREGIONAL RECURRENCE explained in plain language.
Never miss a new study
Get alerted when new LOCOREGIONAL RECURRENCE trials appear
Sign up with your email to follow new studies for LOCOREGIONAL RECURRENCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for breast cancer patients: drug combo aims to prevent return
Disease control Recruiting nowThis study tests whether adding the drug ribociclib to standard hormone therapy can prevent breast cancer from returning in people whose cancer came back in the same area (locoregional recurrence). About 200 adults with hormone receptor-positive, HER2-negative breast cancer will …
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated May 01, 2026 16:00 UTC
-
New hope for breast cancer patients: drug combo may stop return of disease
Disease control Recruiting nowThis study tests whether adding the drug abemaciclib to standard hormone therapy can help prevent breast cancer from returning in people whose cancer came back in the same area (chest, breast, or nearby lymph nodes) after initial treatment. About 290 participants with a specific …
Matched conditions: LOCOREGIONAL RECURRENCE
Phase: PHASE3 • Sponsor: Japanese Foundation for Cancer Research • Aim: Disease control
Last updated May 01, 2026 16:00 UTC